Literature DB >> 9830149

Rapid evaluation in Escherichia coli of antisense RNAs and ribozymes.

C Tatout1, E Gauthier, H Pinon.   

Abstract

The characterization of a simple bacterial system using commercially available plasmids and strains, developed to assess the effectiveness of trans-acting (antisense RNA and ribozymes) RNA in Escherichia coli, is reported. This system was used to test various trans-acting RNA molecules against the expression of the I factor, a functional transposable element from Drosophila melanogaster. For this target, results indicate that antisense RNA efficiency depends on the hybridization length between sense and antisense RNA. The introduction of a single hammerhead ribozyme within the antisense RNAs does not increase its inhibitory activity. These predictions were subsequently confirmed in Drosophila melanogaster.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830149

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  5 in total

1.  Artificial and epigenetic regulation of the I factor, a nonviral retrotransposon of Drosophila melanogaster.

Authors:  E Gauthier; C Tatout; H Pinon
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

2.  Direct selection for ribozyme cleavage activity in cells.

Authors:  Xi Chen; Lisa Denison; Matthew Levy; Andrew D Ellington
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

3.  A structural analysis of in vitro catalytic activities of hammerhead ribozymes.

Authors:  Yu Shao; Susan Wu; Chi Yu Chan; Jessie R Klapper; Erasmus Schneider; Ye Ding
Journal:  BMC Bioinformatics       Date:  2007-11-30       Impact factor: 3.169

4.  Hitting bacteria at the heart of the central dogma: sequence-specific inhibition.

Authors:  Louise Carøe Vohlander Rasmussen; Hans Uffe Sperling-Petersen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2007-08-10       Impact factor: 5.328

5.  (Non-)translational medicine: targeting bacterial RNA.

Authors:  Adam M Dinan; Brendan J Loftus
Journal:  Front Genet       Date:  2013-11-08       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.